|
CCDC90B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.067600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.707410E-01 |
| Normal-vs-Stage2 |
8.250200E-02 |
| Normal-vs-Stage3 |
2.642200E-01 |
| Normal-vs-Stage4 |
1.425030E-01 |
| Stage1-vs-Stage2 |
2.059600E-01 |
| Stage1-vs-Stage3 |
7.967800E-01 |
| Stage1-vs-Stage4 |
5.264400E-01 |
| Stage2-vs-Stage3 |
5.386600E-01 |
| Stage2-vs-Stage4 |
8.099000E-01 |
| Stage3-vs-Stage4 |
7.811600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.651580E-02 |
| Normal-vs-AfricanAmerican |
3.244200E-01 |
| Normal-vs-Asian |
5.852000E-01 |
| Caucasian-vs-AfricanAmerican |
2.372800E-01 |
| Caucasian-vs-Asian |
9.048000E-01 |
| AfricanAmerican-vs-Asian |
7.738400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.476200E-01 |
| Normal-vs-Female |
6.162500E-04 |
| Male-vs-Female |
1.221540E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.998000E-02 |
| Normal-vs-Extreme_Weight |
2.597600E-01 |
| Normal-vs-Obese |
3.242100E-02 |
| Normal-vs-Extreme_Obese |
9.680600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.309600E-01 |
| Normal_Weight-vs-Obese |
8.835400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.375400E-01 |
| Extreme_Weight-vs-Obese |
2.270800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.620200E-01 |
| Obese-vs-Extreme_Obese |
2.268400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.416700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.961620E-02 |
| Normal-vs-Age(61-80Yrs) |
2.471800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.890400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.871800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.244900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.962400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.450100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.578760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.196800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.072000E-02 |
| Normal-VS-Type2 PRCC |
5.610600E-01 |
| Normal-VS-KIRP CIMP |
1.34600000001317E-06 |
| Normal-VS-Unclassified PRCC |
6.849500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.217000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.19449999999877E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
4.479800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.171770E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.435970E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.007500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.909400E-01 |
| Normal-vs-N1 |
1.747880E-02 |
| Normal-vs-N2 |
7.261200E-01 |
| N0-vs-N1 |
3.257900E-02 |
| N0-vs-N2 |
6.479200E-01 |
| N1-vs-N2 |
1.990150E-01 |
|
|
